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Abstract
Background: Articular cartilage undergoes an important maturation process from neonate to
adult that is reflected by alterations in matrix protein organization and increased heterogeneity of
chondrocyte morphology. In the horse, these changes are influenced by exercise during the first
five months of postnatal life. Transcriptional profiling was used to evaluate changes in articular
chondrocyte gene expression during postnatal growth and development.
Methods: Total RNA was isolated from the articular cartilage of neonatal (0–10 days) and adult
(4–5 years) horses, subjected to one round of linear RNA amplification, and then applied to a 9,367element equine-specific cDNA microarray. Comparisons were made with a dye-swap experimental
design. Microarray results for selected genes (COL2A1, COMP, P4HA1, TGFB1, TGFBR3, TNC)
were validated by quantitative polymerase chain reaction (qPCR).
Results: Fifty-six probe sets, which represent 45 gene products, were up-regulated (p < 0.01) in
chondrocytes of neonatal articular cartilage relative to chondrocytes of adult articular cartilage.
Conversely, 586 probe sets, which represent 499 gene products, were up-regulated (p < 0.01) in
chondrocytes of adult articular cartilage relative to chondrocytes of neonatal articular cartilage.
Collagens, matrix-modifying enzymes, and provisional matrix non-collagenous proteins were
expressed at higher levels in the articular cartilage of newborn foals. Those genes with increased
mRNA abundance in adult chondrocytes included leucine-rich small proteoglycans, matrix
assembly, and cartilage maintenance proteins.
Conclusion: Differential expression of genes encoding matrix proteins and matrix-modifying
enzymes between neonates and adults reflect a cellular maturation process in articular
chondrocytes. Up-regulated transcripts in neonatal cartilage are consistent with growth and
expansion of the articular surface. Expression patterns in mature articular cartilage indicate a
transition from growth to homeostasis, and tissue function related to withstanding shear and
weight-bearing stresses.
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Background
At birth, articular cartilage is relatively homogeneous.
That is, the cellular and molecular structures do not vary
from site to site topologically across the joint [1-6]. During postnatal maturation in mammals, articular cartilage
undergoes architectural reorganization associated with
growth and changes in biomechanical demands on the
tissue [1-3,5]. For equine articular chondrocytes, the process is characterized by altered matrix protein production
patterns with exercise during the first five months of postnatal life [2,7]. This adaptation affects the tissue longitudinally from the joint surface to deeper layers, as well as
topologically across a joint between weight-bearing and
non-weight-bearing areas [1,2,8]. Sites that receive lowlevel constant weight-bearing load have higher amounts
of glycosaminoglycan and proteoglycan, providing resistance to compressive stresses [1,8]. Sites that receive high
sheer stress through intermittent peak loading and movement have high levels of type II collagen for tensile
strength [1,8]. As noted, these changes in architectural
heterogeneity develop in the articular cartilage of foals
during the first 5 months of life [2,3]. However, if exercise
is restricted, articular cartilage fails to fully develop these
characteristics of maturation. In addition, re-establishing
normal levels of activity in a previously exercise-restricted
foal is ineffective at promoting proper articular cartilage
adaptation [2,3]. In this same population of horses, van
den Hoogen et al. found that proteoglycan synthesis
increased with free pasture exercise over the first 5 months
followed by a light exercise regimen [9]. These results suggest that the architecture of articular cartilage changes
with age and mechanical stimulation. If normal exercise is
severely restricted in a horse during the first 5 months of
postnatal life, then adaptation of matrix and anchorage
proteins in articular cartilage to weight- and shear-stresses
can be permanently compromised.
Postnatal articular cartilage changes have been characterized in several mammals. The transition from isotropic to
anisotropic architecture was demonstrated in the articular
cartilage of the proximal tibia of rats by Sasano et al. and
in the medial femoral condyle of rabbits by Hunziker et al.
[5,10]. Increased postnatal matrix deposition of type II
collagen occurs in the rabbit and rat [10,11]. Changes and
topological differences in cross-linking of collagens with
age in postnatal horses as well as in humans have been
established [7,8,12]. Moreover, moderate exercise in
young adult dogs, guinea pigs, and humans seem to cause
zonal changes in proteoglycan and collagen content that
allow for adaptation and strengthening of articular cartilage [13]. While past studies have described biochemical
and histological changes to articular cartilage during the
postnatal period, much remains unexplained with regards
to the cellular mechanisms that achieve growth and
matrix re-organization. The current study utilizes microar-
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ray-based transcriptional profiling to assess differential
gene expression between neonatal and mature articular
cartilage across a large subset of genes in the equine
genome. In addition to individual genes, including those
with established functional annotation in cartilage, the
approach enables expression differences between gene
ontology categories to be compared. The hypothesis
tested was that changes in chondrocyte gene expression
occur during postnatal maturation and reflect a functional
transition from growth and matrix synthesis to cartilage
homeostasis.

Materials and methods
Cartilage Collection and RNA Isolation
Full-thickness articular cartilage was harvested and pooled
from the proximal and distal humerus, the proximal and
distal femur, the proximal and distal tibia, proximal
radius, and proximal ulna of seven 0–10 day old foals and
nine 4–5 year old adults. In the foals, particular attention
was paid to distinguish regions with and without cartilage
canals because articular cartilage with vasculature is destined to become calcified cartilage or to undergo hypertrophic differentiation and the formation of bone. Only
cartilage without vascular canals was utilized in this study.
Cartilage was rinsed in sterile phosphate-buffered saline,
snap-frozen in liquid nitrogen, and then pulverized into
powder while still frozen. Total RNA was isolated in a
buffer of 4 M guanidinium isothiocyanate, 0.1 M TrisHCl, 25 mM EDTA (pH 7.5) with 1% (v/v) 2-mercaptoethanol, followed by differential alcohol and salt precipitations [14-16]. Finally, RNA samples were re-purified
using QIAGEN RNeasy columns following the manufacturer's protocol.
Transcriptional Profiling
Microarray slides were printed with clones selected from a
cDNA library generated using mRNA purified from the
articular cartilage of a 15-month old Thoroughbred male
[17]. Creation of the cDNA library is described in Coleman et al. [18]. Probe sets on the microarray slides were
prepared and printed as described by Band et al. [19].
Transcriptional profile differences of neonatal and mature
articular chondrocytes were assessed by four separate
neonate-adult comparisons. For each experimental sample, 2 μg of total RNA received one round of linear amplification primed with oligo-dT (Invitrogen – SuperScript
RNA Amplification System) [20,21]. Amplified RNA (2
μg) was then used as template to create fluorescent dyecoupled single-stranded aminoallyl-cDNA probes (Invitrogen – Superscript Indirect cDNA Labeling System,
Molecular Probes – Alexa Fluor 555 and 647 Reactive
Dyes).

Microarray slides were pre-hybridized in 20% formamide,
5× Denhardt's, 6× SSC, 0.1% SDS, and 25 μg/ml tRNA for
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45 minutes as described by Band et al. [19]. Slides were
then washed five times in deionized water and once in
isopropanol and spun dry at 700 g for 3 minutes [19].
Two dye-coupled fluorescent cDNA probes representing
one of each of the two experimental groups (neonate vs.
adult) were combined with 1× hybridization buffer (1×
Slide Hybridization Buffer #1, Ambion, cat no. 8801),
incubated for 2 minutes at 95°C, and then applied to the
slide under a glass lifterslip for 48 hours at 42°C. All
hybridizations were performed in duplicate with a dye
swap to eliminate possible dye bias [22]. Post-hybridization washes were each for 5 minutes as follows: first wash
– 1× SSC, 0.2% SDS, 0.1 mM DTT at 42°C; second wash
– 0.1× SSC, 0.2% SDS, 0.1 mM DTT at room temperature;
third and fourth washes – 0.1× SSC and 0.1 mM DTT at
room temperature. After the post-hybridization washes,
the slides were spun dry under argon gas at 700 g for 3
minutes. Each slide was coated once in DyeSaver 2 (Genisphere) and allowed to dry for 10 minutes. Scanning was
performed using a GenePix 4100A scanner with the spot
intensities computed using GENEPIX 6.0 image analysis
software (Axon Instruments/Molecular Devices).
Statistics and Analysis
After scanning, median intensities adjusted for background for each pair of spots were lowess-normalized for
every slide using the bottom row of each of the 48 printing
blocks. This bottom row contains a constant set of positive and negative controls. A one sample t-test was applied
to the log ratios accounting for dye-swapped slides. Corresponding microarray IDs for statistically significant probe
sets were queried with an annotation database [23]. The
data extracted were putative gene symbols and gene
descriptions from a series of BLAST searches of the ESTs to
the curated protein, RNA, and genomic Reference
Sequence Databases [24]. Gene ontology (GO) annotation was derived from batch queries of the DAVID Bioinformatics tool or manually through individual NCBI
Entrez Gene queries [25,26]. Statistical data, fold change
quantities, and GO annotations were managed within an
Excel spreadsheet (Microsoft, Redmond, WA). Expression
patterns were analyzed using Expression Analysis Systematic Explorer (EASE) standalone software [27]. Microarray
data were submitted to NCBI Gene Expression Omnibus
as the data series GSE10303 for platform GPL6423 with
sample accessions GSM260356, GSM260358, GSM2603
61, and GSM260363 [28].
Validation of Microarray Hybridization Results with qPCR
Differential expression for selected genes was validated via
quantitative polymerase chain reactions (qPCR). Briefly,
total RNA was reverse-transcribed (RT) into cDNA using
an oligo-dT primer with the Promega Reverse Transcription System (Promega, cat. no. A3500). Quantitative
"real-time" PCR (ABI Systems 7900HT Fast Real-Time
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PCR System, Applied Biosystems, Foster City, CA) was
performed using TaqMan Gene Expression Master Mix
(Applied Biosystems, cat. no. 4369016) and intron-spanning primer/probe sets (Assays-by-Design, Applied Biosystems) created from equine genomic sequence data
(Ensembl – http://www.ensembl.org/Equus_caballus/ind
ex.html; UCSC Genome Browser – http://genome.ucsc.e
du) (Table 1). Each primer/probe set was tested for specificity and performance and had to meet two criteria: (1) no
amplification with genomic DNA, minus-RT, and water
controls; and (2) amplification efficiencies within a range
of 0.9–1.2 as determined by manual serial dilution of a
positive control sample, following Applied Biosystems
recommended performance guidelines. All primer/probe
sets met these specificity and performance criteria. Beta-2microglobulin (B2M), beta-glucuronidase (GUSB), phosphoglycerate kinase 1 (PGK1), and large ribosomal protein P0 (RPLP0) primer/probe sets were evaluated as
potential endogenous control transcripts. Steady state levels of mRNA encoding type II procollagen (COL2A1), cartilage oligomeric matrix protein (COMP), proline 4hydroxylase (P4HA1), transforming growth factor beta
receptor-3 (TGFβR3), and tenascin-C (TNC) were selected
for RT-qPCR validation based on EASE data analyses.
Transforming growth factor beta-1 (TGFβ1) was selected
as a transcript of biological interest that did not demonstrate an expression difference by microarray hybridizations. Results were adjusted for efficiency as measured by
LinRegPCR using the default fit option which measures
the slope of a line containing 4–6 data points and the
highest R2 correlation value [29,30]. Real-time PCR data
were normalized with endogenous control genes GUSB
and RPLP0 according to guidelines set by geNorm stability analyses [31]. Relative expression levels by RT-qPCR
using all 10 equine-specific primer/probe sets were determined individually on 7 neonatal and 9 adult articular
cartilage RNA samples. This included the original 4 neonatal and 4 adult articular cartilage RNA samples used in
the microarray comparisons. A non-parametric MannWhitney-Wilcoxon Rank Sum Test was used to assess statistical significance of qPCR results.

Results
Global assessment of transcriptome differences
Nine thousand three hundred sixty-seven probe sets were
analyzed. A total of 642 probe sets (6.9%) were differentially expressed (p < 0.01; Figure 1b). A volcano plot
shows that 586 probe sets (representing 499 different
genes) were up-regulated in adult chondrocytes relative to
neonates, while 56 probe sets (representing 45 different
genes) of the differentially expressed clones were up-regulated in neonate chondrocytes relative to adults (Figure
1c). Based on a p-value of 0.01, we would expect up to 94
(1% of 9,367) to be differentially expressed by chance,
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Table 1: Primer nucleotide sequences used in RT-qPCR assays for genes described in the study

Gene Name

Gene Symbol

Forward Primer

Reverse Primer

B2M

5-CGGGCTACTCTCCCTGACT-3

5-GTGACGTGAGTAAACCTGAACCTT-3

Beta-glucuronidase

GUSB

5-GCTCATCTGGAACTTTGCTGATTTT-3

5-CTGACGAGTGAAGATCCCCTTTT-3

Phosphoglycerate kinase-1

PGK1

5-GTGGCCTCTGGCATACCT-3

5-CTGCTCTCAGTGCCACAGT-3

Ribosomal protein, large, P0

RPLP0

5-CTGATTACACCTTCCCACTTGCT-3

5-AGCCACAAATGCAGATGGATCA-3

Procollagen, type II, alpha 1

COL2A1

5-CTGGCTTCAAAGGCGAACAAG-3

5-GCACCTCTTTTGCCTTCTTCAC-3

Cartilage oligomeric matrix protein

COMP

5-CGAGCCCGGCATCCA-3

5-CCCAGGGCCTGTGGAG-3

Proline-4-hydroxylase, alpha 1

P4HA1

5-CCTGTCCAGTGCTAGTAGGAAAC-3

5-CCTGTCCAGTGCTAGTAGGAAAC-3

Transforming growth factor beta-1

TGFβ1

5-CCCTGCCCCTACATTTGGA-3

5-TGTACAGGGCCAGGACCTT-3

TGFβR3

5-ACATCATCGAGTTAATCACCCCAAA-3

5-GATCCTTTCGAGAAGGTCTTATGTCA-3

TNC

5-TCAGCCATCACTACCAAGTTCAC-3

5-GAACCTCAGTAGCAGTCAAATCTCT-3

Beta-2-microglobulin

Transforming growth factor beta
receptor 3
Tenascin-C

yielding a False Discovery Rate (FDR) of 14.64% (94/
642).
Functional patterns of differential gene expression
Significant genes with a > 2 fold difference in either direction (neonate > adult, adult > neonate) were analyzed by
Expression Analysis Systematic Explorer (EASE) (Table 2).

Overrepresentation was determined by EASE score, a
Fisher's exact test measure. Gene overrepresentation was
strongest for extracellular and extracellular matrix categories (Table 2). Differential expression was also represented
in categories involving skeletal development, cell adhesion, heparan sulfate proteoglycan metabolism, as well as
receptor activity and organogenesis. Categories not overrepresented in this analysis, however, include growth factor activity and cell proliferation.
Cartilage matrix proteins and modifying enzymes
Many of the differentially expressed transcripts identified
in the annotation categories are cartilage matrix proteins.
Collagen types II (COL2A1), and IX (COL9A1, COL9A2,
COL9A3), and tenascin-C (TNC) were upregulated in
neonatal chondrocytes relative to adult chondrocytes
(Table 3). Other genes demonstrating greater transcript
abundance in neonates relative to adults include collagenmodifying enzymes like lysyl oxidase-like 2 (LOXL2), proline-4-hydroxylase alpha 1 subunit (P4HA1), and the
basement membrane protein nidogen-2 (NID2) (Table
3). Transcripts encoding matrix proteins that are more

abundant in adults include chondroadherin (CHAD), cartilage intermediate layer protein (CILP), cartilage oligomeric matrix protein (COMP), fibronectin (FN), frizzledrelated protein (FRZB), and procollagen C-endopeptidase
enhancer 2 (PCOLCE2) (Table 4). Redundant cDNA
probe sets present on the microarray displayed strong
concordance.
Growth factors
With the exception of transforming growth factor-beta
receptor 3 (TGFβR3) and fibroblast growth factor 10
(FGF10), no transcripts encoding growth factors or
growth factor receptors showed > 2 fold-difference on the
microarray hybridizations (Table 5). Several additional
growth factors and growth factor receptors (FGFRL1,
GDF5, GDF6, IGF2R, IGFBP5) demonstrated a significant
change in steady state mRNA levels (p < 0.01), but with
only minimal fold change differences between neonatal
and adult samples (Table 5).
Quantification of differential gene expression with realtime qPCR
Steady state transcript abundance was measured for
potential endogenous control genes B2M, GUSB, PGK1,
and RPLP0. Messenger RNA levels for all 4 of these genes
were similar (p > 0.05) between neonates and adults by
the microarray hybridizations. Stability was also assessed
by geNorm VBA applet, and RPLP0 and GUSB were the
two most stable endogenous control gene candidates (M
= 0.552). As a result, they were selected as the most suita-
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Figure
cDNA microarray
1
transcriptional profiling indicates differential gene expression between neonatal and adult articular cartilage
cDNA microarray transcriptional profiling indicates differential gene expression between neonatal and adult
articular cartilage. (a) Histomorphometric comparison of isotropic articular cartilage structure in the equine neonate and
the anisotropic structure in adults. (b) A p-value histogram of differentially expressed transcripts from the 9,367 element
equine-specific cDNA microarray demonstrates that just under 7% of the clones had significance at p < 0.01. (c) A volcano plot
of the neonatal versus adult comparison; points above the horizontal black line are transcripts demonstrating differential
expression with a significance of p < 0.01. The two vertical black lines correspond to 2-fold up- and down-regulation. Degree
of statistical significance is displayed along the vertical axis and expression fold change along the horizontal axis.

ble transcripts for the normalization of the target genes of
biological interest further analyzed by RT-qPCR.
Five mRNA transcripts (COL2A1, COMP, P4HA1,
TGFβR3, TNC) that displayed differential expression in
the microarray hybridizations and one transcript (TGFβ1)
that did not were selected for RT-qPCR validation (Figure
2). These genes were selected to confirm the microarray
findings and because of the functional annotation of their
encoded proteins. Relative quantification of target transcripts revealed significant increases in neonatal mRNA
abundance for COL2A1, P4HA1, and TNC (Figure 2).
Fold change differences were similar or slightly greater

than what was measured by microarray profiles. Moreover, increased COMP and TGFβR3 transcript abundance
for adult cartilage was also validated by RT-qPCR while
TGFβ1 confirmed the microarray finding of no significant
difference (Figure 2).

Discussion
Transcriptional profiling results indicate that maturationdependent differences in cellular activity exist between
neonatal and adult equine articular chondrocytes. These
differences likely reflect age-dependent adaptation that
occurs as chondrocytes are acting to meet changing functional needs. Neonatal articular cartilage is in a state of
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Table 2: EASE analysis of genes with significant fold differences greater than 2
GO System

Gene Category

List Hits

List Total

Population Hits

Population Total

EASE Score

Official Gene
Symbols

Cellular Component

Extracellular

19

37

258

2760

3.27E-10

CHAD, CILP, CLU,
COL2A1, COL9A1,
COMP, CP, FMOD,
FN1, FRZB, GAS6,
LOXL2, NID2, PRELP,
SERPINA5, SULF1,
THSD1, TIMP2, TNC

Cellular Component

Extracellular Matrix

11

37

101

2760

3.17E-07

CHAD, COL2A1,
COL9A1, COMP,
FMOD, FN1, NID2,
PRELP, THSD1, TIMP2,
TNC

Molecular Function

Extracellular Matrix
Structural Constituent

6

40

35

2830

9.16E-05

CHAD, COL2A1,
COL9A1, COMP, FN1,
PRELP

Biological Process

Skeletal Development

6

38

55

2780

0.00068

ANKH, COL2A1,
COMP, DLX5, FRZB,
PRELP

Biological Process

Cell Adhesion

8

38

151

2780

0.00315

COL2A1, COL9A1,
COMP, FN1, LOXL2,
NID2, THSD1, TNC

Cellular Component

Extracellular Space

5

37

71

2760

0.01273

CP, FN1, LOXL2,
SERPINA5, SULF1

Biological Process

Development

11

38

410

2780

0.03681

ANKH, BOC, CLU,
COL2A1, COL9A1,
COMP, DLX5, FRZB,
LOXL2, PRELP,
TGFBR3

Biological Process

Heparan Sulfate
Proteoglycan
Metabolism

2

38

5

2780

0.06484

HS3ST3A1, SULF1

Biological Process

Acute-phase Response

2

38

6

2780

0.07731

FN1, SERPINA5

Molecular Function

Scavenger Receptor
Activity

2

40

6

2830

0.07996

KIAA1822, LOXL2

Biological Process

Organogenesis

7

38

231

2780

0.08131

ANKH, COL2A1,
COL9A1, FRZB, PRELP

Molecular Function

Transmembrane
Receptor Activity

5

40

122

2830

0.08470

FRZB, KIAA1822,
LOXL2, PDGFRL, TNC

Molecular Function

Receptor Activity

7

40

233

2830

0.09626

FRZB, KIAA1822,
LOXL2, NR1D2,
PDGFRL, TGFBR3,
TNC

"GO System" represents the major ontological system (i.e., cellular component, biological process, or molecular function). "Gene category" is a
descriptive term shared by a group of genes. "List hits" are the numbers of differentially abundant transcripts that belong to the gene category. "List
total" is the number of differentially expressed genes within the corresponding cellular component, biological process, or molecular function
system. "Population hits" represent the total number of genes found on the microarray possessing that specific gene category annotation (e.g.,
extracellular, skeletal development, etc.). "Population Total" represents the total number of genes found on the microarray possessing that GO
system annotation. "EASE score" is a measure of overrepresentation that scales the results of a statistical analysis (Fisher's exact test) by biasing
against categories supported by few genes. Gene symbols of differentially expressed probe sets represented for each gene category are given in the
last column.
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Table 3: Cartilage matrix proteins and modifying enzymes upregulated in neonatal cartilage relative to adult cartilage

Gene Name

Gene Symbol

GenBank ID(s)

Fold Change (N/A)

p-value

Procollagen, type II alpha 1

COL2A1

CX594994.1

2.77

0.0161

CX595082.1

2.31

0.0454

CX595094.1

7.86

0.0037

CX596509.1

3.74

0.0059

CX597852.1

2.62

0.0503

CX599228.1

2.70

0.0557

CX599236.1

2.68

0.0402

CX600104.1

2.64

0.0546

CX601257.1

3.43

0.0192

CX602198.1

2.72

0.0488

CX603857.1

2.43

0.0758

CX604122.1

2.93

0.0246

CX604856.1

2.19

0.0310

CX605192.1

1.75

0.0055

CX605350.1

2.68

0.0447

CX605856.1

8.10

0.0040

Procollagen, type IX

COL9A1

COL9A2
COL9A3

Lysyl oxidase-like 2

Nidogen-2

Proline 4-hydroxylase, alpha 1

Tenascin-C

LOXL2

NID2

P4HA1

TNC

CX602049.1

4.61

0.0029

CX605273.1

6.70

0.0108

CX597674.1

2.11

0.0304

CX594271.1

1.93

0.0083

CX603177.1

1.41

0.0889

CX600483.1

2.98

0.0051

CX598127.1

2.52

0.0033

CX596324.1

2.71

0.0003

CX600869.1

2.31

0.0037

CX605971.1

2.38

< 0.0001

CX592418.1

2.23

< 0.0001

CX593372.1

4.81

0.0043

CX601743.1

2.74

0.0430

CX601953.1

2.25

0.0715

CX603922.1

3.09

0.0062

CX604542.1

2.39

0.0016

CX605854.1

4.72

0.0054

Gene Name & Gene Symbol: gene identity of best BLAST match homologue to cDNA or plasmid; GenBank ID: Accession number of equine cDNA
spotted on the microarray; Fold Change (N/A): Relative Neonate/Adult fold change; p-value: one-sample t-test p-value for probe across the four
biological replicates in the total sample set.
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Table 4: Cartilage matrix proteins and modifying enzymes upregulated in adult cartilage relative to neonatal cartilage

Gene Name

Gene Symbol

GenBank ID(s)†

Fold Change (A/N)

p-value

Cartilage intermediate layer protein

CILP

CX598636.1
CX599486.1

5.96
7.83

0.0102
0.0042

Cartilage oligomeric matrix protein

COMP

CX592689.1
CX592951.1
CX593277.1
CX597915.1
CX600749.1
CX601142.1

2.53
2.25
2.09
2.63
2.43
2.29

0.0036
0.0014
0.0164
0.0041
0.0035
0.0038

Fibronectin

FN1

CX594011.1
CX596432.1
CX598808.1
CX600436.1
CX601190.1
CX602630.1
peFN840
peFN-C1

4.65
3.35
3.86
4.18
4.62
1.31
6.03
7.24

0.0075
0.0192
0.0313
0.0024
0.0017
0.1717
0.0013
0.0018

Frizzled-related protein

FRZB

CX597477.1
CX598716.1
CX604177.1

3.53
3.82
2.70

0.0159
0.0227
0.0015

Heparan sulfate 3-O-sulfotransferase 3A1

HS3ST3A1

CX595901.1

2.61

0.0061

Matrix metalloproteinase 1 (collagenase)

MMP1

peMMP1

4.61

0.0080

Nexin-1

PN-1

CX604123.1

2.27

0.0071

Procollagen C-endopeptidase enhancer 2

PCOLCE2

CX597547.1
CX601347.1
CX604313.1
CX605197.1
CX605337.1

4.63
2.08
1.89
4.64
4.31

0.0041
0.0036
0.0013
0.0322
0.0038

Serine proteinase inhibitor, clade A, member 5

SERPINA5

CX598843.1

3.27

0.0038

Sulfatase 1

SULF1

CX596711.1

2.83

0.0043

Tissue inhibitor of metallopeptidase 2

TIMP2

CX605012.1

4.48

0.0050

Gene Name & Gene Symbol: gene identity of best BLAST match homologue to cDNA or plasmid; GenBank ID: Accession number of equine cDNA
spotted on the microarray (†: some IDs represent plasmid designation); Fold Change (A/N): Relative Adult/Neonate fold change; p-value: onesample t-test p-value for probe across the four biological replicates in the total sample set.

growth and expansion. The chondrocytes are secreting
large amounts of extracellular matrix (ECM) in response
to the expanding articular surface. This can be seen with
the upregulation of collagen types II and IX in neonatal
chondrocytes. Microarray hybridization data showing
increased abundance of type II collagen transcripts in neonatal articular cartilage relative to adult articular cartilage
was validated at 3.75-fold by RT-qPCR (p < 0.01, Figure
2).

In neonatal articular chondrocytes, there is also an upregulation of collagen-modifying enzymes necessary for the
assembly of ECM; this includes proline 4-hydroxylase
(P4H) and lysyl oxidase. P4H is a catalyst necessary for the
modification of proline for collagen triple helix formation
[32]. Increased transcript abundance for P4HA1 indicated
by microarray in neonatal articular cartilage relative to
adult articular cartilage was validated at 3.71-fold by RTqPCR (p < 0.01, Figure 2). Lysyl oxidases catalyze the
cross-linking and condensation of collagen fibrils by oxi-
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Gene Symbol

Total Probe Sets

Median Fold Difference
(N/A)

Probe sets with p < 0.01

Probe sets with p < 0.05

Bone morphogenetic protein 2
Bone morphogenetic protein 4
Bone morphogenetic protein 6
Bone morphogenetic protein receptor
1a
Bone morphogenetic protein receptor
2
Connective tissue growth factor
Fibroblast growth factor 2
Fibroblast growth factor 10
Fibroblast growth factor 18
Fibroblast growth factor receptor 1
Fibroblast growth factor receptor 2
Fibroblast growth factor receptor 3
Fibroblast growth factor receptor-like
1
Growth differentiation factor 5
Growth differentiation factor 6
Growth differentiation factor 10
Insulin-like growth factor 1
Insulin-like growth factor receptor 1
Insulin-like growth factor 2 receptor
Insulin-like growth factor binding
protein 4
Insulin-like growth factor binding
protein 5
Insulin-like growth factor binding
protein 6
Insulin-like growth factor binding
protein 7
Transforming growth factor β1
Transforming growth factor β1-like 1
Transforming growth factor β2
Transforming growth factor β3
Transforming growth factor β
receptor 1
Transforming growth factor β
receptor 2
Transforming growth factor β
receptor 3
Transforming growth factor β
receptor associated protein 1

BMP2
BMP4
BMP6
BMPR1A

6
1
1
1

0.99
0.81
0.79
0.91

0
0
0
0

1
0
0
0

BMPR2

2

0.73

0

0

CTGF
FGF2
FGF10
FGF18
FGFR1
FGFR2
FGFR3
FGFRL1

1
2
1
1
2
3
2
4

0.82
0.76
0.35
1.03
0.97
0.59
0.74
0.84

0
0
0
0
0
0
0
1

0
2
1
0
0
2
2
2

GDF5
GDF6
GDF10
IGF1
IGFR1
IGF2R
IGFBP4

1
1
2
1
2
1
1

0.90
1.07
0.74
0.89
0.86
1.12
0.83

1
1
0
0
0
0
0

1
1
1
1
0
1
0

IGFBP5

3

1.05

1

1

IGFBP6

1

0.78

0

0

IGFBP7

3

0.85

0

1

TGFβ1
TGFβ1L1
TGFβ2
TGFβ3
TGFβR1

2
2
5
2
1

1.11
0.98
0.96
0.86
0.73

0
0
0
0
0

0
0
1
0
0

TGFβR2

1

0.70

0

0

TGFβR3

5

0.45

3

5

TGFβRAP1

1

0.91

0

0

Gene Name & Gene Symbol: gene identity of best BLAST match homologue to cDNA or plasmid; Total probe sets: Number of probe sets on the microarray representing the gene based on best
BLAST match results; Median Fold Difference (N/A): Relative median Neonate/Adult fold change (bold represents fold difference > 2); Probe sets with p < 0.01 or 0.05: number of probe sets for
each gene meeting these criteria by one-sample t-test.
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dizing lysine and hydroxylysine residues to become lysyl
and hydroxylysyl aldehydes [33]. The condensation of
collagens helps increase tensile strength within cartilage.
As such, the upregulation of LOXL2 is likely necessary for
adaptation to shear and weight-bearing stresses. When
immature bovine articular cartilage is treated with the
lysyl oxidase inhibitor β-aminopropionitrile in an in vitro
model, a reduction of tensile integrity was noted [34].
These findings are consistent with neonatal expression of
collagen modifying enzymes in parallel to higher levels of
collagen synthesis during growth and biomechanical
adaptation.
Increased steady state levels of tenascin-C (TNC) transcripts in neonatal cartilage are also consistent with a
remodeling process. This protein is upregulated in tissues
at developmental stages, during wound healing, and during tumorigenesis [35-37]. TNC has an anti-adhesive Nterminal domain and a pro-adhesive C-terminal domain;
its multiple domains allow for interactions with many
ECM components, including fibronectin [38,39]. Thus,
the presence of TNC affects cells within the ECM, notably
by inhibiting cell adhesion and focal adhesion kinase-signaling while stimulating growth [35,37]. The effects of
TNC on matrix organization have been well characterized
in the developing chick forebrain, in healing skin wounds,
and in tumorigenesis [37,40]. Tenascin-C is expressed
within the developing limb; however, it disappears
throughout the limb and the growth plate during endochondral ossification, though expression can still be
detected in postnatal articular cartilage [38,41]. As maturation occurs in normal articular cartilage and the provisional matrix is replaced by adapted anisogenous matrix,
TNC expression decreases [38,41]. The current data are
consistent with previous TNC findings for chicken,
mouse, and rat. Theories for the postnatal presence and
then reduction of TNC within the articular cartilage
include maintenance of the chondrocyte phenotype,
capability of the cells to attach and then detach in an
expanding matrix, and the utilization of signal transduction for mediating chondrocyte developmental fate [38].
Another interesting finding was elevated steady state levels of transcripts encoding nidogen-2 (NID2) in neonatal
chondrocytes (Table 3). NID2 is one of the two nidogen
matrix-binding isoforms found to exist in mammals
which are involved in basement membrane assembly [4244]. Nidogens are typically localized to basement membranes, but have also been associated with development
and tissue remodeling, including limb formation [45,47].
Thus far, it has been shown that nidogens interact with
perlecan, collagen types I and IV, integrins, and laminins
[44,45,48]. Matrix-binding proteins like nidogens also
have the capacity to play a role in the adaptive maturation
process of a growing neonate, which seems to be best

http://www.biomedcentral.com/1471-2474/9/149

characterized by the expansion of collagens within the
provisional immature matrix and the modifications of the
matrix postnatally to withstand stresses.
The spectrum of upregulated transcripts in mature articular cartilage is consistent with chondrocytes that have
transitioned functionally from cartilage growth to cartilage maintenance. Besides elevated adult steady state transcript levels for matrix molecules like cartilage
intermediate layer protein (CILP), cartilage oligomeric
matrix protein (COMP), and fibronectin (FN), the data
also reveal other clones that contribute to the roles of
chondrocytes in mature cartilage (Tables 2 and 4). With
regards to matrix proteins, differences in levels of CILP
mRNA detected by microarray hybridization correspond
to previous reports of protein accumulation in the extraterritorial matrix of adult cartilage with age [49]. It is
believed that this protein causes increased calcium pyrophosphate dihydrate deposition in cartilage, impairs
chondrocyte responsive to IGF-1, and subsequently hinders matrix repair [50]. Moreover, increased levels of
mRNA encoding COMP were also found in adult cartilage; RT-qPCR quantified this difference as 3.5-fold (Figure 2). COMP is a homopentameric glycoprotein that
binds to type II collagen interterritorially to stabilize the
ECM [51,52]. COMP mRNA upregulation has been previously described during different stages of limb and joint
development with species-dependence as well as with
mechanical compression [52,53]. Increased fibronectin
mRNA hybridization in adult articular cartilage parallels
findings from Burton-Wurster et al. (Table 4) [54].
Fibronectin is an important extracellular matrix adhesion
glycoprotein for cell-matrix signaling. Besides genes
which encode matrix proteins, categories of many other
genes which typify the maintenance of a heterogeneous
matrix are represented. For example, genes with functional roles in collagen-, glycosaminoglycan-, and proteoglycan-binding are upregulated in adult articular
chondrocytes (Table 4). Once cartilage growth and adaptation are complete, type II collagen expression is sustained yet at lower levels as the chondrocyte's primary role
transforms to tissue maintenance. Increased mRNA levels
of matrix metalloproteinase-1 (MMP1), tissue inhibitor of
metallopeptidases-2 (TIMP2), and chondroprotective
nexin-1 (PN1) are also consistent with cartilage maintenance (Table 4). With maturation, gene expression in
articular chondrocytes reflects tissue homeostasis and a
perpetuation of the ability to withstand shear and weightbearing stresses.Histological examination of articular cartilage reveals increased cellularity per unit volume of cartilage in neonatal animals compared to adults. A stable
chondrocyte number and expanding matrix may be a primary mechanism in achieving the lower cell density
observed in adult articular cartilage. In comparing pro- vs.
anti- cell proliferation, cell cycle, and apopoptic genes in
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Figure 2 measurement of differential gene expression
RT-qPCR
RT-qPCR measurement of differential gene expression. Quantification of transcript abundance indicates significant upregulation of COMP (b) and TGFβR3 (e) gene expression in adult articular cartilage relative to neonatal articular cartilage. In
contrast, gene expression for COL2A1 (a), P4HA1 (c), and TNC (d) are significantly up-regulated in neonatal articular cartilage
relative to adult articular cartilage. Expression of TGFβ1 (f) was not significantly different between neonatal and adult samples.
The RT-qPCR data for all six target genes confirm the results of microarray hybridization experiments. Data are presented as
box and whisker plots indicating lowest value, first (0.25) quartile, median, third quartile (0.75), and highest value. Mathematical
means of expression are indicated below each age group, and mean fold differences for each target gene are also given numerically as "Mean FC" under the abscissa. ** (p < 0.01).
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the transcriptional profiles, questions with regards to cell
proliferation and cell cycle regulation persist. From the
transcriptional profiles, it is difficult to say definitively at
either stage of maturation that the chondrocytes are in a
state of proliferation or quiescence. Relatively few probes
representing these functional categories were significantly
up-regulated in neonates. Moreover, though many more
(25) gene probes representing these ontology categories
were upregulated in adults, distribution did not favor cell
proliferation or growth factor activity. Growth factors
such as TGFβ1 and IGF1 have been shown to induce
chondrocyte proliferation and ECM production with limb
development and in culture, and the importance of factors and receptors like BMPR1A, GDF5, and TGFβR2 in
the maintenance of postnatal articular have also been
demonstrated [44,55-58]. However, FGF10 and TGFβR3
were the only genes related to growth factor activity with
> 2 fold difference between adult and neonatal articular
cartilage (Table 5). Increased steady state levels of TGFβR3
in articular cartilage for adults were validated by qPCR at
2.70-fold (p < 0.01). While transcript levels for growth
factors were relatively similar, it is possible that growth
factor activity in postnatal articular cartilage maturation is
regulated primarily at a post-transcriptional level. Growth
factors sequestered within the extracellular matrix of articular cartilage have been shown to become functionally
activated by enzymes like matrix metalloproteinases
[59,60].
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Conclusion
Previous studies of postnatal articular cartilage maturation in mammals have focused on age-dependent changes
in the structural and biochemical organization of the
matrix. The current data extends this knowledge by using
transcriptional profiling to compare gene expression
between neonatal and adult chondrocytes in equine articular cartilage. Seven percent (642) of the 9,367 probe sets
on an equine-specific microarray were differentially
expressed (p < 0.01), organizing primarily into ontology
categories related to extracellular matrix, skeletal development, and cell adhesion. Collagens, matrix-modifying
enzymes, and provisional matrix proteins were expressed
at higher levels in the articular cartilage of newborn foals.
Transcripts encoding leucine-rich small proteoglycans,
matrix assembly, and cartilage maintenance proteins were
found at higher steady state levels in adult articular
chondrocytes. Microarray data for COL2A1, COMP,
P4HA1, TGFB1, TGFBR3, and TNC were validated by
quantitative PCR. Overall, the findings support the
hypothesis that gene expression changes in articular cartilage during postnatal maturation reflect a functional transition of chondrocytes from growth and matrix synthesis
in the neonate to cartilage homeostasis in the adult.
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